Table of Contents
About This Report Pharma faces a number of key resistors to growth including the impending 2011 patent cliff which is set to erode USD 78 billion in global branded sales from drugs facing patent expiry over the 201014 period (plus USD 32 billion from continued erosion of already expired brands). Price cuts, reimbursement restrictions and growing regulatory pressure are further set to limit sales growth going forward. What...More »
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
Talk to Alison
+1 (805) 652 26 26
"Analytical Tool - Hematological Cancers" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in R&D and business development in hematological cancers. It is ...
Market Opportunities for Differentiated Therapeutics Type 2 diabetes is one of the most significant global health concerns of modern times. The size of the diabetes therapeutics market has stimulated a ...
What Pharmaceutical and Biotechnology Companies Want and How to Compete for their Business The overall objective of this study was to provide contract manufacturing organizations (CMOs) a sound basis fo ...
... Treatments, pipelines, and commercial opportunities, spectra intelligence, april 2006, pages: 369 2--melanoma therapeutics - pipeline assessment and market forecasts to 2019, globaldata 3--american cancer ...
... Increased demands on the system in a way that puts business as usual at risk. Diseases vaccinated against vaccine volume per fully immunized child (cm3) immunization cost per child ($) (including ...
Reportlinker.com © Copyright 2013. All rights reserved.